Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sarah McIntyre is active.

Publication


Featured researches published by Sarah McIntyre.


Developmental Medicine & Child Neurology | 2013

A systematic review of interventions for children with cerebral palsy : state of the evidence

Iona Novak; Sarah McIntyre; Catherine Morgan; Lanie Campbell; Leigha Dark; Natalie Morton; Elise Stumbles; Salli-Ann Wilson; Shona Goldsmith

The aim of this study was to describe systematically the best available intervention evidence for children with cerebral palsy (CP).


Obstetrics & Gynecology | 2010

Chorioamnionitis and cerebral palsy: A meta-analysis

Jobe G. Shatrov; Samuel C. M. Birch; Lawrence T. Lam; Julie A. Quinlivan; Sarah McIntyre; George L. Mendz

OBJECTIVE: To examine the relationships between clinical or histological chorioamnionitis and cerebral palsy using a meta-analysis approach. DATA SOURCES: A systematic review of the literature appeared in PubMed between 2000 and 2009 was conducted using the search terms “cerebral palsy” and “infection,” with broad-scope variations in terminology of “white matter damage,” “periventricular leukomalacia,” “cystic periventricular leukomalacia,” “chorioamnionitis,” “intrauterine infection,” “intraventricular hemorrhage,” “funisitis,” “fetal inflammatory response,” “early neonatal sepsis,” “neurological impairment,” “virus,” “bacteria,” “fungi,” and “protozoa,” with variations of suffixes (eg, “viral,” “bacterial,” “fungal,” “protozoan,” etc), and “urinary tract infection,” “bacterial vaginosis,” “bacteriuria,” and “cytokines.” The related key words “gestational age,” “small for gestational age,” “preterm,” and “low birth weight” also were added to the search terms. Only studies published in English were included. METHODS: Three hundred eight articles were retrieved and systematically reviewed independently by two authors. Application of four inclusion criteria led to 15 studies being considered for data abstraction. An exposure was considered relevant if it met the established criteria for clinical or histological chorioamnionitis. The outcome was a diagnosis of cerebral palsy in accordance with established criteria. RESULTS: The data were abstracted onto standard forms, correlated according to eight characteristics, and tabulated. Twelve of the 15 studies contained information on the association between clinical chorioamnionitis and cerebral palsy, and eight studies included information on the association between histological chorioamnionitis and cerebral palsy. The results indicated that there were significant associations between clinical chorioamnionitis or histological chorioamnionitis and cerebral palsy, for clinical chorioamnionitis (&khgr;12=13.91; P<.001) with a pooled odds ratio of 2.42 (95% confidence interval 1.52–3.84), and for histological chorioamnionitis (&khgr;12=6.86; P=.009) with a pooled odds ratio of 1.83 (95% confidence interval, 1.17–2.89). The data suggested increased risks of 140% and 80% for neonates exposed to clinical chorioamnionitis or histological chorioamnionitis, respectively. CONCLUSION: The significant association of clinical or histological chorioamnionitis with cerebral palsy suggested that clinical strategies to prevent or reduce chorioamnionitis would lead to a reduction in cerebral palsy. The culture techniques currently used to diagnose the presence of pathogenic microorganisms during pregnancy need to improve, both in their methodology and in the length of time they require.


Developmental Medicine & Child Neurology | 2013

A systematic review of risk factors for cerebral palsy in children born at term in developed countries

Sarah McIntyre; David Taitz; John Keogh; Shona Goldsmith; Nadia Badawi; Eve Blair

Aim  The aim of this study was to conduct a systematic review in order to identify the risk factors for cerebral palsy (CP) in children born at term. The secondary aim was to ascertain if the potential for prevention of these risk factors has been adequately explored.


Developmental Medicine & Child Neurology | 2010

Consensus research priorities for cerebral palsy: a Delphi survey of consumers, researchers, and clinicians

Sarah McIntyre; Iona Novak; Anne Cusick

Aim  Research funds for cerebral palsy are scarce and competition for them is strong. This study aimed to identify questions for future research that were agreed to be a high priority.


Obstetrics & Gynecology | 2013

Antecedents of cerebral palsy and perinatal death in term and late preterm singletons.

Sarah McIntyre; Eve Blair; Nadia Badawi; John Keogh; Karin B. Nelson

OBJECTIVE: To examine the antecedents of cerebral palsy and of perinatal death in singletons born at or after 35 weeks of gestation. METHODS: From a total population of singletons born at or after 35 weeks of gestation, we identified 494 with cerebral palsy and 508 neonates in a matched control group, 100 neonatal deaths, and 73 intrapartum stillbirths (all deaths in selected birth years). Neonatal death and cerebral palsy were categorized as without encephalopathy, after neonatal encephalopathy, or after neonatal encephalopathy considered hypoxic–ischemic. We examined the contribution of potentially asphyxial birth events, inflammation, fetal growth restriction, and birth defects recognized by age 6 years to each of these outcomes and to intrapartum stillbirths. RESULTS: The odds of total cerebral palsy after potentially asphyxial birth events or inflammation were modestly increased (odds ratio [OR] 1.9, 95% confidence interval [CI] 1.1–3.2 and OR 2.2, 95% CI 1.0–4.2, respectively). However, potentially asphyxial birth events occurred in 34% of intrapartum stillbirths and 21.6% of cerebral palsy after hypoxic–ischemic encephalopathy. Inflammatory markers occurred in 13.9% and 11.9% of these outcomes, respectively. Growth restriction contributed significantly to all poor outcome groups. Birth defects were recognized in 5.5% of neonates in the control group compared with 60% of neonatal deaths and more than half of cases of cerebral palsy without hypoxic–ischemic encephalopathy. In children with cerebral palsy, a potentially asphyxial birth event, inflammation, or both were experienced by 12.6%, whereas growth restriction, a birth defect, or both were experienced by 48.6% (P<.001). CONCLUSION: Fetal growth restriction and birth defects recognized by age 6 years were more substantial contributors to cerebral palsy and neonatal death than potentially asphyxial birth events and inflammation. LEVEL OF EVIDENCE: II


JAMA Pediatrics | 2017

Early, Accurate Diagnosis and Early Intervention in Cerebral Palsy: Advances in Diagnosis and Treatment

Iona Novak; Cathy Morgan; Lars Adde; James A. Blackman; Roslyn N. Boyd; Janice Brunstrom-Hernandez; Giovanni Cioni; Diane L. Damiano; Johanna Darrah; Ann-Christin Eliasson; Linda S. de Vries; Christa Einspieler; Michael Fahey; Darcy Fehlings; Donna M. Ferriero; Linda Fetters; Simona Fiori; Hans Forssberg; Andrew M. Gordon; Susan Greaves; Andrea Guzzetta; Mijna Hadders-Algra; Regina T. Harbourne; Angelina Kakooza-Mwesige; Petra Karlsson; Lena Krumlinde-Sundholm; Beatrice Latal; Alison Loughran-Fowlds; Nathalie L. Maitre; Sarah McIntyre

Importance Cerebral palsy describes the most common physical disability in childhood and occurs in 1 in 500 live births. Historically, the diagnosis has been made between age 12 and 24 months but now can be made before 6 months’ corrected age. Objectives To systematically review best available evidence for early, accurate diagnosis of cerebral palsy and to summarize best available evidence about cerebral palsy–specific early intervention that should follow early diagnosis to optimize neuroplasticity and function. Evidence Review This study systematically searched the literature about early diagnosis of cerebral palsy in MEDLINE (1956-2016), EMBASE (1980-2016), CINAHL (1983-2016), and the Cochrane Library (1988-2016) and by hand searching. Search terms included cerebral palsy, diagnosis, detection, prediction, identification, predictive validity, accuracy, sensitivity, and specificity. The study included systematic reviews with or without meta-analyses, criteria of diagnostic accuracy, and evidence-based clinical guidelines. Findings are reported according to the PRISMA statement, and recommendations are reported according to the Appraisal of Guidelines, Research and Evaluation (AGREE) II instrument. Findings Six systematic reviews and 2 evidence-based clinical guidelines met inclusion criteria. All included articles had high methodological Quality Assessment of Diagnostic Accuracy Studies (QUADAS) ratings. In infants, clinical signs and symptoms of cerebral palsy emerge and evolve before age 2 years; therefore, a combination of standardized tools should be used to predict risk in conjunction with clinical history. Before 5 months’ corrected age, the most predictive tools for detecting risk are term-age magnetic resonance imaging (86%-89% sensitivity), the Prechtl Qualitative Assessment of General Movements (98% sensitivity), and the Hammersmith Infant Neurological Examination (90% sensitivity). After 5 months’ corrected age, the most predictive tools for detecting risk are magnetic resonance imaging (86%-89% sensitivity) (where safe and feasible), the Hammersmith Infant Neurological Examination (90% sensitivity), and the Developmental Assessment of Young Children (83% C index). Topography and severity of cerebral palsy are more difficult to ascertain in infancy, and magnetic resonance imaging and the Hammersmith Infant Neurological Examination may be helpful in assisting clinical decisions. In high-income countries, 2 in 3 individuals with cerebral palsy will walk, 3 in 4 will talk, and 1 in 2 will have normal intelligence. Conclusions and Relevance Early diagnosis begins with a medical history and involves using neuroimaging, standardized neurological, and standardized motor assessments that indicate congruent abnormal findings indicative of cerebral palsy. Clinicians should understand the importance of prompt referral to diagnostic-specific early intervention to optimize infant motor and cognitive plasticity, prevent secondary complications, and enhance caregiver well-being.


Developmental Medicine & Child Neurology | 2014

What constitutes cerebral palsy in the twenty-first century?

Hayley Smithers-Sheedy; Nadia Badawi; Eve Blair; Christine Cans; Kate Himmelmann; Ingeborg Krägeloh-Mann; Sarah McIntyre; Jennie Slee; Peter Uldall; Linda Watson; Meredith Wilson

Determining inclusion/exclusion criteria for cerebral palsy (CP) surveillance is challenging. The aims of this paper were to (1) define inclusion/exclusion criteria that have been adopted uniformly by surveillance programmes and identify where consensus is still elusive, and (2) provide an updated list of the consensus concerning CP inclusion/exclusion when a syndrome/disorder is diagnosed.


Developmental Neurorehabilitation | 2010

‘Just like you’: A disability awareness programme for children that enhanced knowledge, attitudes and acceptance: Pilot study findings

Nicole L Ison; Sarah McIntyre; Sophie Rothery; Hayley Smithers-Sheedy; Shona Goldsmith; Samantha Parsonage; Liz Foy

Purpose: Participation of people with disabilities is influenced by environmental and contextual factors. Disability awareness programmes aim to increase knowledge and acceptance of disability. This study evaluated a disability awareness programme for students aged 9–11 in Australia. Method: Pre–post questionnaires and focus groups evaluated the programme. The intervention took a cognitive-behavioural approach including a person with a disability co-presenting. Students (n = 147) participated in two sessions of discussions, written activities, demonstrations and disability simulation activities. Results: Significant improvements (p < 0.001) in knowledge, attitudes and acceptance of disability were evident immediately following the intervention. Focus group analyses further demonstrated these findings. Conclusions: A brief disability awareness programme for children improved knowledge, attitudes and acceptance of disability in the short-term. Further research is required to identify the potential impact of such programmes on inclusion and social participation of people with disabilities both inside and outside of the school setting.


Developmental Medicine & Child Neurology | 2016

Temporal trends in cerebral palsy by impairment severity and birth gestation

Susan M Reid; Elaine Meehan; Sarah McIntyre; Shona Goldsmith; Nadia Badawi; Dinah Reddihough

Our aim was to build on previous research indicating that rates of cerebral palsy (CP) in the Australian state of Victoria are declining, and examine whether severity of impairments is also decreasing.


Developmental Medicine & Child Neurology | 2016

A special supplement: findings from the Australian Cerebral Palsy Register, birth years 1993 to 2006

Hayley Smithers-Sheedy; Sarah McIntyre; Catherine S. Gibson; Elaine Meehan; Heather Scott; Shona Goldsmith; Linda Watson; Nadia Badawi; Karen Walker; Iona Novak; Eve Blair

To briefly outline the strengths and limitations of cerebral palsy (CP) registers, and to report on findings of the Australian Cerebral Palsy Register (ACPR) pertaining to a population cohort of children with CP.

Collaboration


Dive into the Sarah McIntyre's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eve Blair

University of Western Australia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Linda Watson

Telethon Institute for Child Health Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alison Loughran-Fowlds

Children's Hospital at Westmead

View shared research outputs
Researchain Logo
Decentralizing Knowledge